SCHOTT Pharma debuts ultra-low temperature compatible polymer syringe

Published: 13-May-2025

SCHOTT TOPPAC prefillable polymer syringes have been proven to protect drugs at -180 °C

Drug containment and delivery solutions expert SCHOTT Pharma has introduced SCHOTT TOPPAC freeze polymer syringes, which can protect medications at temperatures as low as  -180 °C.

This will allow the safe and effective transport of sensitive biologics — especially cell and gene threapies — which are currently making a splash in the pharmaceutical market. 

Recent studies confirm that SCHOTT Pharma’s prefillable polymer syringes maintain optimal functionality and integrity at these extreme temperatures, ensuring the sterile barrier and compatibility with sensitive drugs.

“Innovation is a key strategic driver for us. Our enhanced polymer syringe offers a valuable alternative to existing storage solutions, ultimately benefiting patients with severe or rare diseases,” says Andreas Reisse, CEO of SCHOTT Pharma.

 

Given the complexity and specialisation of these therapies, they require stringent storage and transportation conditions, including ultra-low temperatures.

Traditionally, cryo bags have been used for such purposes. However, SCHOTT Pharma's optimised SCHOTT TOPPAC® freeze prefillable polymer syringes now offer an advanced alternative.

 

Reliable drug storage and delivery at -180 °C

In latest studies SCHOTT Pharma has rigorously tested the functionalities of their prefillable polymer syringes under low-temperature conditions, assessing factors such as container closure integrity, silicone leachables, drug compatibility, Break Loose Gliding Force (BLGF) of the plunger, TRC opening torque, sterility barrier, optical properties and mechanical stability.

The results demonstrate that these syringes perform flawlessly at -180 °C.

"Our focus is on optimising products to serve the patient, the pharmaceutical company, and the medication. With our prefillable polymer syringes, we have successfully addressed all these dimensions," explains Christoph Zauner, Head of Product Management Polymer Solutions at SCHOTT Pharma.

SCHOTT Pharma's advanced polymer syringes are manufactured at its facilities in Müllheim, Germany, and St. Gallen, Switzerland.

More information on SCHOTT TOPPAC® freeze prefillable polymer syringes from SCHOTT Pharma: https://www.schott-pharma.com/en/products/syringes/schott-toppac-freeze

Relevant companies

You may also like